Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.

Aadi Bioscience Inc

AADI
2,89
0,06 (2,12%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 23:24:49
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
24/1/202520:34EDGAR2Form SCHEDULE 13D/A - General Statement of Acquisition of..
21/1/202522:54EDGAR2Form PREM14A - Preliminary proxy statements relating to..
30/12/202423:04EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
23/12/202423:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/12/202423:34EDGAR2Form 3 - Initial statement of beneficial ownership of..
23/12/202423:26EDGAR2Form SCHEDULE 13D/A - General Statement of Acquisition of..
20/12/202412:08EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
20/12/202412:05EDGAR2Form 8-K - Current report
20/12/202400:30PRNUSAadi Bioscience Transforms with In-Licensing of Novel ADC..
06/11/202422:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202414:05EDGAR2Form 8-K - Current report
06/11/202414:00PRNUSAadi Bioscience Announces Financial Results for the Third..
30/10/202421:05PRNUSAadi Bioscience to Report Third Quarter 2024 Results and..
04/10/202401:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/10/202401:01EDGAR2Form 144 - Report of proposed sale of securities
01/10/202423:35EDGAR2Form SC 13D/A - General Statement of Acquisition of..
30/9/202412:06EDGAR2Form 8-K - Current report
19/9/202422:13EDGAR2Form 8-K - Current report
05/9/202423:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/9/202423:51EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
03/9/202416:40EDGAR2Form 144 - Report of proposed sale of securities
22/8/202422:15EDGAR2Form 8-K - Current report
21/8/202403:21EDGAR2Form 8-K - Current report
20/8/202423:00PRNUSAadi Bioscience Provides PRECISION1 Trial and Corporate..
07/8/202422:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/8/202414:02EDGAR2Form 8-K - Current report
07/8/202414:00PRNUSAadi Bioscience Announces Financial Results for the Second..
06/8/202400:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/7/202422:05PRNUSAadi Bioscience to Report Second Quarter 2024 Results and..
14/6/202422:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202422:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202422:18EDGAR2Form 8-K - Current report
05/6/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202418:26EDGAR2Form 144 - Report of proposed sale of securities
29/5/202422:05PRNUSAadi Bioscience to Participate in the Jefferies Healthcare..
23/5/202423:30PRNUSAadi Bioscience Presents New Nonclinical Data Demonstrating..
08/5/202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202414:07EDGAR2Form 8-K - Current report
08/5/202414:00PRNUSAadi Bioscience Announces Financial Results for the First..
01/5/202414:01PRNUSAadi Bioscience to Report First Quarter 2024 Results and..
09/4/202414:00PRNUSAadi Bioscience to Present New Non-clinical Data..
17/3/202413:00PRNUSAadi Bioscience Presents New Subgroup Analysis of Patients..
13/3/202413:00PRNUSAadi Bioscience Announces Financial Results for the Fourth..
06/3/202414:00PRNUSAadi Bioscience to Report Fourth Quarter and Full-Year 2023..
05/3/202422:30PRNUSAadi Bioscience to Present Multiple Posters at the American..
05/3/202401:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202401:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 2,83 Min: 2,8004 Max: 2,95
Chiusura: 2,83

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network